China Pharmaceuticals
Showing all 10 results
-
China NMPA (Order No. 28): Administrative Measures for Drugs Registration
$350.00 Add to cart -
China NMPA (Order No.4): Administrative Measures for Drugs Importation
$350.00 Add to cart -
China NMPA (Order No.48,2020) : CDE Communication During Drug R&D and Technical Evaluation,
$200.00 Add to cart -
China NMPA: Approval of Active Pharmaceutical Ingredients (API), Pharmaceutical Excipients and Pharmaceutical Packaging Materials for Drug Products No.146, November 30, 2017
$100.00 Add to cart -
China’s NMPA Decree No. 101: Regulations for The Administration of Overseas Inspection of Pharmaceutical & Medical Devices
$200.00 Add to cart -
China’s NMPA Order No. 56 of 2019: Improving Related Issues Concerning Drug Evaluation, Approval and Supervision (DMF for API, Pharmaceutical Packaging Materials and Excipient
$100.00 Add to cart -
China’s NMPA Technical Guidelines: Marketing Registration of OTC Chemical Drugs (July 2020) in China
$200.00 Add to cart -
China’s NMPA: List of the First Batch of Rare Diseases
$5.00 Add to cart -
NMPA Order No.82, 2020: the Issuance of Working Procedures for Review of Breakthrough Therapies in China
$200.00 Add to cart -
NMPA: Guidance for Clinical Evaluation of Proton/Carbon Ion Therapy System
$100.00 Add to cart